Biocatalysis for Pharmaceuticals—Status and Prospects for a Key Technology
- 31 January 2000
- journal article
- review article
- Published by Elsevier BV in Metabolic Engineering
- Vol. 2 (1), 42-48
- https://doi.org/10.1006/mben.1999.0138
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Microbial Conversion of Indene to Indandiol: A Key Intermediate in the Synthesis of CRIXIVANMetabolic Engineering, 1999
- Chiral-based therapeuticsNature Biotechnology, 1997
- Process development for the production of the (S)-acid precursor of a novel elastase inhibitor (L-694,458) through the lipase-catalyzed kinetic resolution of a β-lactam benzyl esterJournal of Fermentation and Bioengineering, 1997
- Enzyme engineering aspects of biocatalysis: Cofactor regeneration as exampleBiotechnology & Bioengineering, 1996
- Generation of polyketide libraries via combinatorial biosynthesisTrends in Biotechnology, 1996
- Asymmetric bioreduction of a β-tetralone to its corresponding (S)-alcohol by the yeast Trichosporon capitatum MY 1890Journal of Fermentation and Bioengineering, 1996
- Development of a large-scale continuous substrate feed process for the biotransformation of simvastatin byNocardia s.p.Biotechnology & Bioengineering, 1991
- Bioconversion of avermectin into 27-OH avermectinJournal of Industrial Microbiology & Biotechnology, 1990
- The enzymatic transformation of water‐insoluble reactants in nonaqueous solvents. Conversion of cholesterol to cholest‐4‐ene‐3‐one by a Ncardia sp.Biotechnology & Bioengineering, 1975
- The influence of dissolved oxygen partial pressure on the level of various enzymes in mouse LS cellsBiotechnology & Bioengineering, 1968